Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000547616 | SCV000642739 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-28 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001170645 | SCV001333239 | benign | Cardiomyopathy | 2017-11-28 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840644 | SCV002100016 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840645 | SCV002100017 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840646 | SCV002100018 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840643 | SCV002100019 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001726228 | SCV003821808 | uncertain significance | not provided | 2022-02-14 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001700143 | SCV001918900 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV001726228 | SCV001963537 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004537981 | SCV004719727 | likely benign | TTN-related disorder | 2019-06-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |